V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20191250 | 20123570 | 1.68 | 95 | Palliative (P) | 2018-01-28 | 2018-02-04 | CETUXIMAB + IRINOTECAN + FLUOROURACIL | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101726330 |
| 20191255 | 20123571 | 1.7 | 69.9 | null | null | 2016-10-15 | Cetuximab + FOLFIRI cycle 2 onwards | Y | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101611846 |
| 20191258 | 20123572 | 1.76 | 87 | Palliative (P) | 2021-06-27 | 2021-07-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100716067 |
| 20191260 | 20123573 | 1.59 | 75.8 | Adjuvant (A) | 2017-12-24 | 2018-07-27 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101241365 |
| 20191263 | 20123574 | 1.62 | 52.5 | Adjuvant (A) | 2019-12-30 | 2020-01-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101170613 |
| 20191270 | 20123575 | 1.74 | 53.5 | Palliative (P) | 2019-03-16 | 2019-04-06 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100335798 |
| 20191271 | 20123576 | 1.76 | 76.1 | Neo-adjuvant (N) | 2021-12-06 | 2022-02-16 | Docetaxel | 02 | N | DOCETAXEL | 101553139 |
| 20191272 | 20123577 | 1.66 | 83 | Palliative (P) | 2018-09-05 | 2018-09-05 | Docetaxel | 02 | N | DOCETAXEL | 101375588 |
| 20191274 | 20123578 | 1.7 | 77 | null | 2018-07-18 | 2018-08-04 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101104953 |
| 20191275 | 20123579 | 1.59 | 60.8 | 03 | 2016-11-06 | 2016-11-18 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101268825 |
| 20191296 | 20123580 | 1.66 | 48 | null | 2019-05-25 | 2019-06-30 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101505778 |
| 20191297 | 20123581 | 1.7 | 69.05 | null | 2016-09-30 | 2016-10-23 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101738203 |
| 20191301 | 20123582 | 1.51 | 68.6 | Palliative (P) | 2017-02-09 | 2017-02-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100440743 |
| 20191302 | 20123583 | 1.54 | 49.05 | Palliative (P) | 2020-01-16 | 2020-01-23 | Cetuximab + FLUOROURACIL + FOLINIC ACID + IRINOTECAN | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101167678 |
| 20191314 | 20123584 | 1.81 | 77.65 | Palliative (P) | 2018-05-31 | 2018-10-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | Y | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101042213 |
| 20191315 | 20123585 | 1.59 | 53.8 | null | 2018-02-27 | 2018-04-02 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101642941 |
| 20191316 | 20123586 | 1.55 | 56.5 | Palliative (P) | 2019-06-02 | 2019-12-19 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100705012 |
| 20191320 | 20123587 | 1.78 | 73.8 | null | 2019-09-20 | 2019-09-29 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101251238 |
| 20191327 | 20123588 | 1.63 | 58 | Palliative (P) | 2017-10-05 | 2017-10-05 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | DOCETAXEL | 101269396 |
| 20191329 | 20123589 | 1.69 | 70 | Palliative (P) | 2018-11-22 | 2018-11-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 101699092 |
| 20191330 | 20123590 | 1.69 | 109 | Neo-adjuvant (N) | 2021-11-11 | 2021-11-11 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101526951 |
| 20191332 | 20123591 | 1.77 | 71.4 | Palliative (P) | 2019-03-01 | 2019-03-01 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100430320 |
| 20191335 | 20123592 | 1.81 | 39.9 | Palliative (P) | 2018-05-23 | 2018-05-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101124157 |
| 20191339 | 20123593 | 1.92 | 96 | Palliative (P) | 2019-10-18 | 2019-10-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100046389 |
| 20191342 | 20123594 | 1.72 | 81.5 | null | 2017-02-07 | 2017-02-24 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 101656916 |
| 20191346 | 20123595 | 1.51 | 72.4 | Palliative (P) | 2021-03-29 | 2021-03-29 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100800698 |
| 20191348 | 20123596 | 1.67 | 70 | Palliative (P) | 2019-12-23 | 2020-01-13 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CAPECITABINE + GEMCITABINE | 100727144 |
| 20191349 | 20123597 | 1.72 | 102.2 | 03 | 2018-11-01 | 2018-11-01 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101486168 |
| 20191351 | 20123598 | 1.76 | 73.5 | Palliative (P) | 2017-05-18 | 2017-05-19 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101345723 |
| 20191352 | 20123599 | 1.63 | 77.8 | Palliative (P) | 2017-05-23 | 2017-05-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101510714 |
| 20191357 | 20123600 | 1.55 | 74 | Palliative (P) | null | 2018-09-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100477738 |
| 20191359 | 20123601 | 1.74 | 98 | null | 2017-09-13 | 2017-09-25 | Docetaxel 100mg/m2 (21 day) | 02 | null | DOCETAXEL | 100577113 |
| 20191361 | 20123602 | 1.69 | 65.9 | null | 2019-10-06 | 2019-11-07 | CETUXIMAB + IRINOTECAN + MDG | 2 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101685676 |
| 20191365 | 20123603 | 1.7 | 88.2 | Adjuvant (A) | 2018-12-12 | 2019-03-06 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101044932 |
| 20191369 | 20123604 | 1.7 | 91.2 | Palliative (P) | null | 2016-04-14 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100374941 |
| 20191370 | 20123605 | 1.75 | 52.9 | Palliative (P) | 2016-04-29 | 2016-04-29 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 101651281 |
| 20191374 | 20123606 | 1.84 | 61 | null | null | 2017-09-02 | Cetuximab + FOLFIRI cycle1 | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101356438 |
| 20191375 | 20123607 | 1.55 | 75.8 | Palliative (P) | 2017-11-21 | 2017-12-07 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100149860 |
| 20191378 | 20123608 | 1.59 | 77.4 | null | 2018-11-10 | 2019-03-21 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101773848 |
| 20191379 | 20123609 | 1.62 | 73 | Palliative (P) | 2018-01-08 | 2018-01-22 | Gemcitabine + Capecitabine | 99 | N | CAPECITABINE + GEMCITABINE | 100707470 |
| 20191383 | 20123610 | 1.7 | 98 | Palliative (P) | 2018-12-12 | 2019-03-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100966669 |
| 20191385 | 20123611 | 1.83 | 98 | Palliative (P) | null | null | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101836329 |
| 20191388 | 20123612 | 1.7 | 78 | Palliative (P) | 2017-07-22 | 2017-08-05 | Docetaxel | 02 | N | DOCETAXEL | 101700953 |
| 20191391 | 20123613 | 1.78 | 77.5 | Adjuvant (A) | 2019-04-01 | 2019-04-04 | Cetuximab + FOLFIRI cycle1 | 02 | N | CAPECITABINE + GEMCITABINE | 101743599 |
| 20191392 | 20123614 | 1.52 | 66.6 | Palliative (P) | 2019-03-28 | 2019-04-10 | Cetuximab + FOLFIRI cycle1 | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101334640 |
| 20191397 | 20123615 | 1.85 | 88 | Palliative (P) | 2016-10-28 | 2016-10-30 | CETUXIMAB + IRINOTECAN + MDG | null | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101358797 |
| 20191405 | 20123616 | 1.97 | 104.8 | Palliative (P) | 2017-05-24 | 2017-05-29 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100022492 |
| 20191409 | 20123617 | 1.54 | 87.7 | null | 2016-07-13 | 2016-08-03 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100909639 |
| 20191412 | 20123618 | 2 | 54.4 | Palliative (P) | 2018-06-06 | 2018-06-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100082914 |
| 20191413 | 20123619 | 1.61 | 91 | Neo-adjuvant (N) | 2019-04-02 | 2019-04-02 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 100125702 |